Evidence for a role of human gut microbiota in multiple sclerosis (MS) risk is mounting, yet large variability is seen across studies. This is, in part, due to the lack of standardization of study protocols, sample collection methods, and sequencing approaches.
Objective:
This study aims to address the effect of a household experimental design, sample collection, and sequencing approaches in a gut microbiome study in MS subjects from a multi-city study population.
Methods:
We analyzed 128 MS patient and cohabiting healthy control pairs from the International MS Microbiome Study (iMSMS). A total of 1005 snap-frozen or desiccated Q-tip stool samples were collected and evaluated using 16S and shallow whole-metagenome shotgun sequencing.
Results:
The intra-individual variance observed by different collection strategies was dramatically lower than inter-individual variance. Shallow shotgun highly correlated with 16S sequencing. Participant house and recruitment site accounted for the two largest sources of microbial variance, while higher microbial similarity was seen in household-matched participants as hypothesized. A significant proportion of the variance in dietary intake was also dominated by geographic distance.
Conclusion:
A household pair study largely overcomes common inherent limitations and increases statistical power in population-based microbiome studies.
BererKGerdesLACekanaviciuteE, et al. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proc Natl Acad Sci USA2017; 114(40): 10719–10724.
2.
AlfredssonLOlssonT. Lifestyle and environmental factors in multiple sclerosis. Cold Spring Harbor Perspect Med2019; 9: a028944.
3.
Ochoa-ReparazJKirbyTOKasperLH. The gut microbiome and multiple sclerosis. Cold Spring Harbor Perspec Med2018; 8: a029017.
4.
De LucaFShoenfeldY. The microbiome in autoimmune diseases. Clin Exp Immunol2019; 195: 74–85.
5.
CekanaviciuteEYooBBRuniaTF, et al. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proc Natl Acad Sci USA2017; 114: 10713–10718.
6.
JangiSGandhiRCoxLM, et al. Alterations of the human gut microbiome in multiple sclerosis. Nat Commun2016; 7: 12015.
7.
ChenJChiaNKalariKR, et al. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci Rep2016; 6: 28484.
8.
McDonaldWICompstonAEdanG, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol2001; 50(1): 121–127.
9.
BaranziniSEOksenbergJR. The genetics of multiple sclerosis: From 0 to 200 in 50 Years. Trends Genet2017; 33(12): 960–970.
McArdleBHAndersonMJ. Fitting multivariate models to community data: A comment on distance-based redundancy analysis. Ecology2001; 82: 290–297.
12.
ZapalaMASchorkNJ. Multivariate regression analysis of distance matrices for testing associations between gene expression patterns and related variables. Proc Natl Acad Sci USA2006; 103(51): 19430–19435.
13.
CaporasoJGLauberCLWaltersWA, et al. Ultra-high-throughput microbial community analysis on the illumina HiSeq and MiSeq platforms. ISME J2012; 6(8): 1621–1624.
14.
CaporasoJGKuczynskiJStombaughJ, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods2010; 7(5): 335–336.
15.
ShannonCE. The mathematical theory of communication. 1963. MD Comput1997; 14: 306–317.
16.
ChaoA. Non-parametric estimation of the number of classes in a population. Scand J Stat1984; 11: 265–270.
17.
LozuponeCKnightR. UniFrac: A new phylogenetic method for comparing microbial communities. Appl Environ Microbiol2005; 71(12): 8228–8235.
18.
BrayJRCurtisJT. An ordination of the upland forest communities of southern Wisconsin. Ecol Monogr1957; 27: 325–349.
19.
KellyBJGrossRBittingerK, et al. Power and sample-size estimation for microbiome studies using pairwise distances and PERMANOVA. Bioinformatics2015; 31(15): 2461–2468.
20.
DidionJPMartinMCollinsFS. Atropos: Specific, sensitive, and speedy trimming of sequencing reads. PeerJ2017; 5: e3720.
21.
LangmeadBTrapnellCPopM, et al. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol2009; 10(3): R25.
22.
HillmannBAl-GhalithGAShields-CutlerRR, et al. Evaluating the information content of shallow shotgun metagenomics. Msystems2018; 3(6): e00069-18.
JandaJMAbbottSL. 16S rRNA gene sequencing for bacterial identification in the diagnostic laboratory: Pluses, perils, and pitfalls. J Clin Microbiol2007; 45(9): 2761–2764.
25.
JovelJPattersonJWangW, et al. Characterization of the gut microbiome using 16S or shotgun metagenomics. Front Microbiol2016; 7: 459.
26.
GuptaVKPaulSDuttaC. Geography, ethnicity or subsistence-specific variations in human microbiome composition and diversity. Front Microbiol2017; 8: 1162.
27.
RothschildDWeissbrodOBarkanE, et al. Environment dominates over host genetics in shaping human gut microbiota. Nature2018; 555(7695): 210–215.
28.
YatsunenkoTReyFEManaryMJ, et al. Human gut microbiome viewed across age and geography. Nature2012; 486(7402): 222–227.
29.
OdamakiTKatoKSugaharaH, et al. Age-related changes in gut microbiota composition from newborn to centenarian: A cross-sectional study. BMC Microbiol2016; 16: 90.
30.
CostelloEKLauberCLHamadyM, et al. Bacterial community variation in human body habitats across space and time. Science2009; 326(5960): 1694–1697.
31.
HaroCRangel-ZunigaOAAlcala-DiazJF, et al. Intestinal Microbiota Is Influenced by Gender and Body Mass Index. PLoS ONE2016; 11(5): e0154090.
32.
GentileCLWeirTL. The gut microbiota at the intersection of diet and human health. Science2018; 362(6416): 776–780.
33.
SinghRKChangHWYanD, et al. Influence of diet on the gut microbiome and implications for human health. J Transl Med2017; 15(1): 73.
34.
SaresellaMMendozziLRossiV, et al. Immunological and clinical effect of diet modulation of the gut microbiome in multiple sclerosis patients: A pilot study. Front Immunol2017; 8: 1391.
35.
SuezJKoremTZilberman-SchapiraG, et al. Non-caloric artificial sweeteners and the microbiome: Findings and challenges. Gut Microbes2015; 6(2): 149–155.
36.
DominianniCWuJHayesRB, et al. Comparison of methods for fecal microbiome biospecimen collection. BMC Microbiol2014; 14: 103.
37.
SinhaRChenJAmirA, et al. Collecting fecal samples for microbiome analyses in epidemiology studies. Cancer Epidemiol Biomarkers Prev2016; 25(2): 407–416.
38.
MitraSForster-FrommeKDamms-MachadoA, et al. Analysis of the intestinal microbiota using SOLiD 16S rRNA gene sequencing and SOLiD shotgun sequencing. BMC Genomics2013; 14(Suppl. 5): S16.
39.
RanjanRRaniAMetwallyA, et al. Analysis of the microbiome: Advantages of whole genome shotgun versus 16S amplicon sequencing. Biochem Biophys Res Commun2016; 469(4): 967–977.
40.
FiererNLeffJWAdamsBJ, et al. Cross-biome metagenomic analyses of soil microbial communities and their functional attributes. Proc Natl Acad Sci USA2012; 109(52): 21390–21395.
41.
PoretskyRRodriguez-RLMLuoC, et al. Strengths and limitations of 16S rRNA gene amplicon sequencing in revealing temporal microbial community dynamics. PLoS ONE2014; 9(4): e93827.
42.
FranzosaEAHsuTSirota-MadiA, et al. Sequencing and beyond: Integrating molecular “omics” for microbial community profiling. Nat Rev Microbiol2015; 13(6): 360–372.
43.
GoodrichJKDi RienziSCPooleAC, et al. Conducting a microbiome study. Cell2014; 158(2): 250–262.
44.
AbelesSRJonesMBSantiago-RodriguezTM, et al. Microbial diversity in individuals and their household contacts following typical antibiotic courses. Microbiome2016; 4(1): 39.
45.
LaxSSmithDPHampton-MarcellJ, et al. Longitudinal analysis of microbial interaction between humans and the indoor environment. Science2014; 345(6200): 1048–1052.
46.
SongSJLauberCCostelloEK, et al. Cohabiting family members share microbiota with one another and with their dogs. Elife2013; 2: e00458.
47.
KurilshikovAWijmengaCFuJ, et al. Host genetics and gut microbiome: Challenges and perspectives. Trends Immunol2017; 38(9): 633–647.
48.
AlterMYamoorMHarsheM. Multiple sclerosis and nutrition. Arch Neurol1974; 31: 267–272.
49.
SwankRL. Treatment of multiple sclerosis with low-fat diet. AMA Arch Neurol Psychiatry1953; 69: 91–103.
50.
SwankRLDuganBB. Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet1990; 336(8706): 37–39.
51.
SwankRLGoodwinJ. Review of MS patient survival on a Swank low saturated fat diet. Nutrition2003; 19(2): 161–162.
52.
LeongEMSempleSJAngleyM, et al. Complementary and alternative medicines and dietary interventions in multiple sclerosis: What is being used in South Australia and why. Complement Ther Med2009; 17(4): 216–223.
53.
YadavVShintoLBourdetteD. Complementary and alternative medicine for the treatment of multiple sclerosis. Expert Rev Clin Immunol2010; 6(3): 381–395.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
